Methfol-ER Tablet is a combination pharmaceutical formulation containing Methylcobalamin 1500 mcg, Vitamin B6 (Pyridoxine) 20 mg, and Folic Acid 5 mg, designed to address deficiencies and support neurological and hematological health. Methylcobalamin, an active form of Vitamin B12, plays a critical role in nerve regeneration, DNA synthesis, and red blood cell formation. Vitamin B6 is essential for amino acid metabolism, neurotransmitter synthesis, and immune function, while Folic Acid is vital for nucleic acid synthesis and cellular division. Methfol-ER is indicated for the treatment of peripheral neuropathies, megaloblastic anemia due to folate or Vitamin B12 deficiency, and conditions requiring enhanced neuroprotection and hematopoiesis. The extended-release formulation ensures sustained plasma levels, promoting improved bioavailability and reduced dosing frequency. This combination is beneficial in managing diabetic neuropathy, alcoholic neuropathy, and other neurological disorders associated with vitamin deficiencies. Methfol-ER should be administered under medical supervision, with dosage adjusted according to patient-specific clinical conditions and laboratory parameters. Caution is advised in patients with hypersensitivity to any component or those with pre-existing conditions such as Leber’s disease. Adverse effects are generally mild but may include gastrointestinal discomfort or allergic reactions. Regular monitoring is recommended to optimize therapeutic outcomes and ensure safety.